KISSH SARS-CoV-2 Neutralizing Antibodies Detection Kit (ELISA)

Test Principle

The SARS-COV-2 Neutralizing Antibody Detection Kit (ELISA) adopts the enzyme-linked immune method to simulate the virus neutralization process to qualitative analyze the new coronavirus neutralizing antibody in human blood samples. The kit contains two key components: HRP labeled recombinant SARS-COV-2 RBD protein (HRP-RBD) and human ACE-2 receptor protein (ACLi-2). Firstly, after the sample and quality control sample were pre incubated with hrp-rbd, the neutralizing antibody of the sample was combined with HRP-RBD to form a mixture of neutralizing antibodies.Then the mixture was added to the enzyme plate pre coated with ACE-2 protein and incubated for a period of time. The unbound 1IRP-R13D and the bound with non neutralizing antibody will bind to ACE-2 protein on the plate, while the mixture of neutralizing antibody will be removed during washing. After the washing step, TMB solution is added. After a period of reaction, the color turns blue. After the termination solution is added, the color turns yellow and the value is read and calculated. The higher the content of SARS-CoV-2 neutralizing antibody in the sample, the lighter the color; the lower the content, the darker the color.

Product Information

Shenzhen Kisshealh Biotechnology Co., Ltd., located in the Pingshan District, Shenzhen, P.R. China. is a diagnostics company focused on the development and manufacture of IVD tests at the Point-of-Care with highly innovative proprietary technology.

We focused on the emerging markets of in vitro pathological diagnosis and immunodiagnosis. We developed, manufactured and successfully launched the in vitro immunodiagnosis platform for cancer and the POCT for infectious, genetic and chronic diseases.

<span style="color: rgb(33, 33, 33); text-transform: none; text-indent: 0px; letter-spacing: normal;" initial;"="" initial;="" 0px;="" normal;="" 255);="" 255,="" rgb(255,="" 2;="" !important;="" inline="" none;="" 600;="" 14px;="" sans-serif;="" arial,="" roboto,="" w3",="" gb="" sans="" "hiragino="" gb",="" hei",="" micro="" "wenquanyi="" sans",="" "droid="" arimo,="" freesans,="" yahei",="" "microsoft="" helvetica,="" grande",="" "lucida="" ui",="" segoe="">At Kissh we work every day to shape the future of in-vitro diagnostic testing. And our people are our best asset, the reason for our track record and our strength while we are moving forward. We live by our fundamental values and incorporate them in everything that we do. Our best asset is ‘Step Forward Every Second’